NDC 50989-101 - Double A ORAL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50989-101
- Package NDCs from labels
- 50989-101-25, 50989-101-17
- Manufacturer
- Vedco, Inc.
- Effective date
- 2017-01-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Double "A" Solution | Vedco, Inc. | 2017-01-17 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50989-101-17 | Double AORAL | 1000 mL in 1 BOTTLE | SOLUTION | 1000 | 2 | |
| 50989-101-25 | Double AORAL | 500 mL in 1 BOTTLE | SOLUTION | 500 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Company | 0bfb32b2-d034-4219-a055-3448f0c424f7 | 2021-02-19 | Warnings, Adverse reactions | LX22YL083G |
| potassium chloride | POTASSIUM CHLORIDE | Zydus Pharmaceuticals (USA) Inc. | 51586c47-1aff-4ce6-8030-89f9eb1bc9ac | 2021-02-08 | Warnings, Adverse reactions | 660YQ98I10 |
| OHM Mucus Relief | ANTIMONIUM CRUDUM, ANTIMONIUM TARTARICUM, CHELIDONIUM MAJUS, FERRUM PHOSPHORICUM, KALI CARBOONICUM, KALI MURIATICUM, KALI SULPHURICUM, MARRUBIUM VULGARE. | OHM PHARMA INC. | f13bff50-7087-46dc-a958-b460a2af6283 | 2021-01-11 | Warnings | 660YQ98I10 |
| Magnesium Sulfate | MAGNESIUM SULFATE HEPTAHYDRATE | Medical Purchasing Solutions, LLC | b6352fbd-d3ee-2d3a-e053-2a95a90a747d | 2020-12-11 | Warnings, Adverse reactions | SK47B8698T |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Lupin Pharmaceuticals,Inc. | 28c49165-d8c9-443a-b000-953b8e1ec55c | 2020-11-20 | Warnings, Adverse reactions | 660YQ98I10 |
| Magnesium Sulfate | MAGNESIUM SULFATE HEPTAHYDRATE | Sagent Pharmaceuticals | a607796c-6676-4d0a-8108-8708fe6769ed | 2020-11-16 | Warnings, Adverse reactions | SK47B8698T |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | Asclemed USA, Inc. | afac6cc5-1ced-4639-b6f6-86f40ef5c30e | 2020-10-29 | Warnings, Adverse reactions | 660YQ98I10 |
| Travasol | LEUCINE, PHENYLALANINE, LYSINE HYDROCHLORIDE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, TYROSINE, SERINE | Baxter Healthcare Corporation | 8543b5be-0f43-4891-9e56-d7c39fe839b5 | 2020-10-07 | Warnings, Adverse reactions | HG18B9YRS7 |
| POTASSIUM CHLORIDE IN DEXTROSE | DEXTROSE AND POTASSIUM CHLORIDE | B. Braun Medical Inc. | e5bbb3e1-ab50-4ec7-a2b4-ce4091712e23 | 2020-07-31 | Warnings, Adverse reactions | 660YQ98I10 |
| MAGNESIUM SULFATE | MAGNESIUM SULFATE HEPTAHYDRATE | Gland Pharma Limited | a9e706ac-9c5f-4b14-b277-53dee195ffc6 | 2020-07-14 | Warnings, Adverse reactions | SK47B8698T |
| Cardioplegic | CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM CHLORIDE | Baxter Healthcare Corporation | 1fd50ce5-2799-4c26-81da-02cf0578dd9e | 2020-06-11 | Warnings, Adverse reactions | 660YQ98I10 |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | ee831456-5962-4d5e-ad0c-69ab85860453 | 2020-06-03 | LX22YL083G | |
| LACTATED RINGERS AND DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, AND DEXTROSE MONOHYDRATE | HF Acquisition Co LLC, DBA HealthFirst | a62cf623-9b8a-37e0-e053-2995a90add5b | 2020-05-21 | Warnings, Adverse reactions | 660YQ98I10 LX22YL083G |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2020-05-14 | Warnings, Adverse reactions | 660YQ98I10 |
| DEXTROSE AND SODIUM CHLORIDE | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE | Fresenius Kabi USA, LLC | b825c9c4-f2fb-4a4a-9d8c-fb020ad07e93 | 2020-04-30 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride | POTASSIUM CHLORIDE | Genus Lifesciences Inc. | 23d818e7-c076-40de-8dc1-0b51ba4be96a | 2020-04-28 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Lupin Pharmaceuticals,Inc. | 1bbacdbb-91fa-4897-a00c-1b293de27b83 | 2020-04-27 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Mylan Pharmaceuticals Inc. | c64ed4c0-1e27-42b3-9625-fb4e0d31e271 | 2020-04-15 | Warnings, Adverse reactions | 660YQ98I10 |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Company | 7de48bdb-9a05-4f2a-bbff-dcfeb284ca6e | 2020-02-27 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose and Electrolyte No. 48 | SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, MONOBASIC POTASSIUM PHOSPHATE, SODIUM CHLORIDE AND DEXTROSE MONOHYDRATE | Baxter Healthcare Company | b283a454-0c20-4fbf-92d3-dae1f3cd3cad | 2020-02-13 | Warnings, Adverse reactions | 660YQ98I10 LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.